Mesenchymal stem cells inhibit MRP-8/14 expression and neutrophil migration via TSG-6 in the treatment of lupus nephritis
Lingli Zhang, Weiwei Chen, Nan Xia, Dan Wu, Honghong Yu, Yuanyuan Zheng, Hongwei Chen, Fei Fei, Linyu Geng, Xin Wen, Shanshan Liu, Dandan Wang, Jun Liang, Wei Shen, Ziyi Jin, Xiaojing Li, Genhong Yao
Journal:BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
IF:3.1
DOI:10.1016/j.bbrc.2023.02.005
PMID:36791546
Published:2023-02-03
research field:分子生物学微生物学食品科学病毒学
Abstract
Abnormal infiltration and activation of neutrophils play a pathogenic role in the development of lupus nephritis (LN). Myeloid-related proteins (MRPs), MRP-8 and -14, also known as the damage-associated molecular patterns (DAMPs), are mainly secreted by activated neutrophils in systemic lupus erythematosus (SLE). Mesenchymal stem cells (MSCs) regulate a variety of immune cells to treat LN, but it is not clear whether MSCs can regulate neutrophils and the expression of MRP-8/14 in LN. Here, we demonstrated that neutrophil infiltration and MRP-8/14 expression were increased in the kidney of MRL/lpr mice and both decreased after MSCs transplantation . Further, the results showed that tumor necrosis factor- (TNF) stimulated gene-6 (TSG-6) in MSCs is necessary for MSCs to inhibit MRP-8/14 expression in neutrophils and neutrophil migration. In addition, small-molecule immunosuppressant had no significant effect on the expression of MRP-8/14 in neutrophils. Therefore, our results suggest that MSCs inhibited MRP-8/14 expression and neutrophil migration by secreting TSG-6 in the treatment of LN.
本文使用的Yeasen产品


